Big Money Forums  

Go Back   Big Money Forums > Big Money Investing - Markets, Real Estate and Trading > Stock Markets and Trading > Stock Picks
Register FAQ Calendar Radio Search Today's Posts Mark Forums Read

Reply
Submit Tools Thread Tools Search this Thread Display Modes
  #1  
Unread 10-27-2010, 07:53 AM
Biotechmaster Biotechmaster is offline
Member
 
Join Date: Jul 2010
Posts: 61
Rep Power: 14
Biotechmaster is on a distinguished road
FDA approval within 4 Weeks (Mcap 24 M$) Shares Out 11 M

THIS STOCK IS FLYING UNDER RADAR . FDA APPROVAL WILL PUSH THIS STOCK TO 5-7 US$ EASILY . FANTASTIC BUYING OPPORTUNITY AT CURRENT LEVELS !

EDAP is another Hot Cancer Play Like BSDM .


Edap Tms ( NASDAQ: EDAP )

Market Cap : 24 Million$
Cash : 15,8 Million$
Price : 2,20 $

Shares Out : 11,1 M <<< LOW FLOAT


EDAP Reports Publication of Long-Term Clinical Results for Largest Cohort of Ablatherm-HIFU Patients




EDAP Media Interview Highlights Prostate Cancer



Positive News Coverage of EDAP's Ablatherm-HIFU treatment: "Man beats prostate cancer thanks to annual screening"





EDAP Submits U.S. FDA 510(k) Application for Marketing Clearance for Sonolith i-move



Press Release Source: EDAP TMS SA On Thursday August 19, 2010, 9:15 am EDT

Marc Oczachowski, EDAP's Chief Executive Officer, commented, "We are actively moving forward in obtaining approval in major lithotripsy markets for our recently developed, innovative Sonolith i-move lithotripter. Our recent 510(k) application to the FDA is a clear milestone for EDAP's expansion in this field. In addition to our high-range fully integrated Sonolith I-sys lithotripter that received 510(k) marketing clearance a year ago, our compact multi-configurations Sonolith i-move device offers a wide range of urinary stones treatment options to mid-size clinics and hospitals, hence covering all lithotripsy market segments. We look forward to working with the FDA in view of approval of our Sonolith i-move, hence providing U.S. patients and physicians with the most versatile advanced treatment option."



510(k) Status Program

Submitters may request information on their 510(k) review status 90 days after the initial log-in date of the 510(k).




Homepage
Reply With Quote
  #2  
Unread 11-11-2010, 07:24 AM
Biotechmaster Biotechmaster is offline
Member
 
Join Date: Jul 2010
Posts: 61
Rep Power: 14
Biotechmaster is on a distinguished road
Buy on any Dip . This stock is ready to move into double digits .



100% BUY



EDAP
Reply With Quote
  #3  
Unread 12-13-2010, 06:27 AM
Biotechmaster Biotechmaster is offline
Member
 
Join Date: Jul 2010
Posts: 61
Rep Power: 14
Biotechmaster is on a distinguished road
EDAP is still significantly undervalued .Dont miss the big Opportunity .GL


Always do your own Due Diligence !!


EDAP TMS ( NASDAQ: EDAP )

Market Cap : 55 Million$
Cash : 11 Million$
Price : 5 $

Shares Out : 11,1 M


Reply With Quote
Reply


Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Google
Forum Jump


All times are GMT -5. The time now is 06:16 AM.

Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.